




Searching News Database: Baxter International
HSMN NewsFeed - 19 Mar 2021
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
Zimmer Biomet Expands Role for Ivan Tornos, Appointing Him to New Chief Operating Officer Post
HSMN NewsFeed - 20 Jan 2020
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
Nevro Names Donald A. Middlebrook to Lead Clinical, Regulatory and Quality
HSMN NewsFeed - 21 Feb 2019
Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
Enzyvant Appoints Industry Veteran Rachelle Jacques as Chief Executive Officer
HSMN NewsFeed - 7 Dec 2017
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
Aptinyx Bolsters Executive Leadership Team with Appointment of Andy Kidd as Chief Commercial Officer
HSMN NewsFeed - 3 Oct 2017
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors
HSMN NewsFeed - 5 Jan 2017
Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
Hologic Appoints President of EMEA and Canada, Completing International Leadership Team
HSMN NewsFeed - 24 Oct 2016
Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments
Baxter Launches HDx Therapy Enabled by THERANOVA to Provide High Performance Hemodialysis Treatments
HSMN NewsFeed - 1 Sep 2016
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
Kamada and Kedrion Seek FDA Approval of Human Rabies Immunoglobulin as a Post-Exposure Treatment
HSMN NewsFeed - 19 Jul 2016
Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer
Monteris Medical Announces Appointment Of Martin J. Emerson As President and Chief Executive Officer
HSMN NewsFeed - 6 Jan 2016
Ivenix, Inc. Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
Ivenix, Inc. Appoints MedTech Industry Veteran Stuart A. Randle as Chief Executive Officer
HSMN NewsFeed - 12 Jun 2015
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
FDA Approves Promacta(R) for New Pediatric Chronic Immune Thrombocytopenia (cITP) Indication
HSMN NewsFeed - 14 Aug 2014
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
Ligand Signs Multi-Program Captisol(R) License Agreement with Avion Pharmaceuticals
HSMN NewsFeed - 7 Aug 2014
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
Gynesonics Names Richard P. Lanigan Vice President, Global Commercialization
HSMN NewsFeed - 27 Mar 2014
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
Baxter Announces Plans to Create Two Separate Leading Global Healthcare Companies
HSMN NewsFeed - 6 Jan 2014
Nikkiso Completes Acquisition of Baxter’s Continuous Renal Replacement Therapy Business
Nikkiso Completes Acquisition of Baxter’s Continuous Renal Replacement Therapy Business
HSMN NewsFeed - 20 Dec 2013
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
Baxter Completes CE Mark Approval for VIVIA Hemodialysis System in Europe
HSMN NewsFeed - 12 Dec 2013
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
Momenta Pharmaceuticals Appoints Michael Franken, M.D. as President, Biosimilars Business
HSMN NewsFeed - 11 Dec 2013
The Female Health Company Names Karen King President and Chief Executive Officer
The Female Health Company Names Karen King President and Chief Executive Officer
HSMN NewsFeed - 9 Dec 2013
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
Kamada Announces Appointment of Amir London as Senior Vice President, Business Development
HSMN NewsFeed - 23 Oct 2013
Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
Baxter Launches HEMOPATCH, an Innovative Sealing Hemostat, in European Union
HSMN NewsFeed - 6 Sep 2013
Baxter Completes Acquisition of Gambro AB and Enhances Global Leadership in Renal Therapies
Baxter Completes Acquisition of Gambro AB and Enhances Global Leadership in Renal Therapies
HSMN NewsFeed - 26 Jul 2013
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
Ligand Receives Orphan Designation for Captisol-Enabled(TM) Topiramate Injection
HSMN NewsFeed - 7 May 2013
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
Baxter Announces Topline Results of Phase III Study of Immunoglobulin for Alzheimer's Disease
HSMN NewsFeed - 14 Mar 2013
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
Spectrum Pharmaceuticals Gains Rights to Pivotal-Stage Captisol-Enabled(R) Melphalan
HSMN NewsFeed - 28 Feb 2013
Auxogyn Appoints Women's Health Leader, Kathryn A. Tunstall, to Board of Directors
Auxogyn Appoints Women's Health Leader, Kathryn A. Tunstall, to Board of Directors
HSMN NewsFeed - 24 Jan 2013
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
Baxter Announces Agreement to Acquire Investigational Hemophilia Compound OBI-1 and Related Assets
HSMN NewsFeed - 25 Jun 2012
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
Baxter Announces FDA Approval for GAMMAGARD LIQUID as a Treatment for Multifocal Motor Neuropathy
HSMN NewsFeed - 28 Feb 2012
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition
HSMN NewsFeed - 7 Feb 2012
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
Ligand Names Nishan de Silva, M.D., Vice President of Corporate Development
HSMN NewsFeed - 10 Oct 2011
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
Ligand Enters Into Global Licensing Agreement With Chiva Pharmaceuticals for Fablyn(R)
HSMN NewsFeed - 31 Aug 2011
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
Baxter Announces FDA Approval of ARTISS Fibrin Sealant for Use in Face-Lift (Facial Rhytidectomy) Procedures
HSMN NewsFeed - 6 May 2011
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
Cytori Announces Clyde W. Shores as Executive Vice President of Marketing & Sales
HSMN NewsFeed - 29 Apr 2011
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
Savient Pharmaceuticals Names Seasoned Pharma Exec Richard Crowley EVP Biopharmaceutical Operations
HSMN NewsFeed - 31 Jan 2011
Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition
Baxter Introduces OLIMEL in Canada as the First Triple-Chamber Bag for Nutrition
HSMN NewsFeed - 2 Dec 2010
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
Baxter and Takeda Complete Agreement for Vero Cell-Based Influenza Vaccines in Japan
HSMN NewsFeed - 29 Oct 2010
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
Baxter Announces Divestiture of U.S. Generic Injectables Business to Hikma Pharmaceuticals
HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
HSMN NewsFeed - 4 Aug 2010
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
Watson Names Sigurdur Oli Olafsson Executive Vice President, Global Generics
HSMN NewsFeed - 1 Jun 2010
Baxter Names New President of Renal Business and New Chief Financial Officer
Baxter Names New President of Renal Business and New Chief Financial Officer
HSMN NewsFeed - 25 Jan 2010
PolyTouch Medical Ltd. Announces The Appointment of William Edelman as Chairman of the Board
PolyTouch Medical Ltd. Announces The Appointment of William Edelman as Chairman of the Board
HSMN NewsFeed - 7 Jan 2010
Hill-Rom Appoints John J. Greisch as President and Chief Executive Officer
Hill-Rom Appoints John J. Greisch as President and Chief Executive Officer
HSMN NewsFeed - 7 Oct 2009
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
Baxter Receives European Commission Approval for CELVAPAN H1N1 Pandemic Influenza Vaccine
HSMN NewsFeed - 5 Oct 2009
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
Baxter Announces the Commercial Launch of HYLENEX at ACEP for Use in Pediatric Rehydration
HSMN NewsFeed - 25 Jun 2009
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
Boston Scientific Announces Retirement of Jim Tobin and Appointment of Ray Elliott as New President and CEO
HSMN NewsFeed - 23 Jun 2009
Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences
Baxter to Acquire Continuous Renal Replacement Therapy Business from Edwards Lifesciences
HSMN NewsFeed - 27 May 2009
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
Agios Pharmaceuticals Appoints David Schenkein, M.D. as CEO and Duncan Higgons as COO
HSMN NewsFeed - 15 Apr 2009
Baxter Enters into Exclusive Distribution Agreement with SIGMA International for Infusion Pumps
Baxter Enters into Exclusive Distribution Agreement with SIGMA International for Infusion Pumps
HSMN NewsFeed - 31 Mar 2009
Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
Angiotech Pharmaceuticals, Inc. announces License Agreement with Baxter International Inc.
HSMN NewsFeed - 16 Mar 2009
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
Data Presented at AAAAI Reinforce Baxter's Commitment to Making GAMMAGARD LIQUID Therapy More Convenient
HSMN NewsFeed - 11 Mar 2009
FDA Classifies Recent Urgent Device Correction on Baxter's COLLEAGUE Infusion Pump as a Class I Recall
FDA Classifies Recent Urgent Device Correction on Baxter's COLLEAGUE Infusion Pump as a Class I Recall
HSMN NewsFeed - 13 Feb 2009
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus
HSMN NewsFeed - 11 Feb 2009
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
AspenBio Appoints Robert Caspari, M.D. as Chief Operating Officer and Chief Medical Officer
HSMN NewsFeed - 22 Dec 2008
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million
HSMN NewsFeed - 23 Sep 2008
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
Halozyme Therapeutics Appoints Head of Endocrinology Clinical Development
HSMN NewsFeed - 2 Sep 2008
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
Halozyme Therapeutics Strengthens Management Team, Appoints Additional Experienced Executives
HSMN NewsFeed - 25 Aug 2008
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
Baxter Announces Licensing Agreement for Innocoll's Gentamicin Surgical Implant in the United States
HSMN NewsFeed - 22 May 2008
CyDex Pharmaceuticals Appoints Theron (Ted) Odlaug, Ph.D. as President and Chief Operating Officer
CyDex Pharmaceuticals Appoints Theron (Ted) Odlaug, Ph.D. as President and Chief Operating Officer
HSMN NewsFeed - 21 May 2008
CONMED Corporation Appoints Joseph Darling President of the CONMED Linvatec Orthopedic Products Unit
CONMED Corporation Appoints Joseph Darling President of the CONMED Linvatec Orthopedic Products Unit
HSMN NewsFeed - 9 Apr 2008
Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
Baxter's V-Link Luer-Activated Device With VitalShield Protective Coating Now Available For Hospitals
HSMN NewsFeed - 25 Mar 2008
Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
HSMN NewsFeed - 20 Mar 2008
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
Baxter Announces FDA Approval of ARTISS Slow-Setting Fibrin Sealant in Treatment of Burn Patients
HSMN NewsFeed - 14 Feb 2008
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
BiPar Names Hoyoung Huh, M.D., Ph.D. President and Chief Executive Officer
HSMN NewsFeed - 25 Jan 2008
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
Baxter Issues Urgent Nationwide Voluntary Recall of Heparin 1,000 Units/mL 10 and 30mL Multi-Dose Vials
HSMN NewsFeed - 7 Jan 2008
Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
Baxter Announces Recombinant Factor IX Development Program For Hemophilia B
HSMN NewsFeed - 21 Dec 2007
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed President and Chief Executive Officer of Solstice Neurosciences, Inc.
HSMN NewsFeed - 20 Dec 2007
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
HSMN NewsFeed - 13 Nov 2007
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
Halozyme Therapeutics Names Matthew R. Hooper Vice President, General Counsel
HSMN NewsFeed - 11 Oct 2007
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
Dennis L. Smith Appointed Executive Chairman to Board of Directors of Solstice Neurosciences, Inc.
HSMN NewsFeed - 6 Sep 2007
Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
Boston Scientific Announces Election of Ray Elliott to Its Board of Directors
HSMN NewsFeed - 6 Aug 2007
Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
Baxter Announces Collaboration for Development of Next-Generation Home Hemodialysis Machine
HSMN NewsFeed - 1 Aug 2007
Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen
Dennis Fenton, Executive Vice President of Operations, Elects to Retire after 25 Years with Amgen
HSMN NewsFeed - 25 Jul 2007
FDA Classifies Baxter's Voluntary Recall Action Regarding Service Documentation as a Class I Recall
FDA Classifies Baxter's Voluntary Recall Action Regarding Service Documentation as a Class I Recall
HSMN NewsFeed - 10 Jul 2007
Spinal Restoration and Baxter Announce Agreement for Developing Spinal Disc Application
Spinal Restoration and Baxter Announce Agreement for Developing Spinal Disc Application
HSMN NewsFeed - 20 Jun 2007
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
Baxter Signs Agreements to Evaluate TISSEEL Use With New, Innovative Therapies
HSMN NewsFeed - 15 May 2007
IR BioSciences Appoints Former VaxGen Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors
IR BioSciences Appoints Former VaxGen Chief Executive Lance K. Gordon Ph.D. to Its Board of Directors
HSMN NewsFeed - 20 Apr 2007
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
Baxter Presents Phase I Inhaled Insulin Study Results at Respiratory Drug Delivery Conference
HSMN NewsFeed - 31 Mar 2007
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
Baxter Announces FDA Approval Of Ceprotin For Severe Congential Protein C Deficiency
HSMN NewsFeed - 6 Feb 2007
Baxter Receives Clearance From U.S. FDA for Ipump Pain Management System 510(k)
Baxter Receives Clearance From U.S. FDA for Ipump Pain Management System 510(k)
HSMN NewsFeed - 15 Dec 2006
Lipoxen Announces $75M Agreement With Baxter to Develop New Blood Clotting Factors
Lipoxen Announces $75M Agreement With Baxter to Develop New Blood Clotting Factors
HSMN NewsFeed - 11 Dec 2006
Advanced Life Sciences Announces Election of Theron (Ted) E. Odlaug, Ph.D. to Its Board of Directors
Advanced Life Sciences Announces Election of Theron (Ted) E. Odlaug, Ph.D. to Its Board of Directors
HSMN NewsFeed - 30 Oct 2006
ARCA Discovery, Inc. Names Thomas Keuer Executive Vice President of Pharmaceutical Operations
ARCA Discovery, Inc. Names Thomas Keuer Executive Vice President of Pharmaceutical Operations
HSMN NewsFeed - 24 Oct 2006
Cyclacel Pharmaceuticals Names John Womelsdorf, Ph.D., Vice President, Business Development
Cyclacel Pharmaceuticals Names John Womelsdorf, Ph.D., Vice President, Business Development
HSMN NewsFeed - 11 Oct 2006
Baxter Announces Launch of BAXJECT(R) II Needle-Less Transfer Device for ADVATE(R)
Baxter Announces Launch of BAXJECT(R) II Needle-Less Transfer Device for ADVATE(R)
HSMN NewsFeed - 3 Oct 2006
Baxter Announces Sale of Transfusion Therapies Business to Texas Pacific Group
Baxter Announces Sale of Transfusion Therapies Business to Texas Pacific Group
HSMN NewsFeed - 7 Sep 2006
Baxter Names Peter Nicklin Corporate Vice President and President, Baxter Europe
Baxter Names Peter Nicklin Corporate Vice President and President, Baxter Europe
HSMN NewsFeed - 27 Jun 2006
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
Halozyme and Baxter Announce Availability of Hylenex for Subcutaneous Delivery of Medications and Fluids
HSMN NewsFeed - 25 May 2006
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
Abraxis BioScience Bolsters Manufacturing and Global Operational Expertise With Key Senior Executives
HSMN NewsFeed - 18 May 2006
Baxter and Jerini Advance Program to Develop Non-Intravenous Hemophilia Therapy
Baxter and Jerini Advance Program to Develop Non-Intravenous Hemophilia Therapy
HSMN NewsFeed - 17 May 2006
Baxter Appoints John Greisch President of International; Treasurer Robert Davis Succeeds Greisch as CFO
Baxter Appoints John Greisch President of International; Treasurer Robert Davis Succeeds Greisch as CFO
HSMN NewsFeed - 9 May 2006
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
Baxter Receives FDA Approval for Ultra-High Dosage Strength of ADVATE for Hemophilia A
Additional items found! 172

Members Archive contains
172 additional stories matching:
Baxter International
(Password required)
Baxter International
(Password required)